AR012723A1 - Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos - Google Patents

Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos

Info

Publication number
AR012723A1
AR012723A1 ARP980102327A ARP980102327A AR012723A1 AR 012723 A1 AR012723 A1 AR 012723A1 AR P980102327 A ARP980102327 A AR P980102327A AR P980102327 A ARP980102327 A AR P980102327A AR 012723 A1 AR012723 A1 AR 012723A1
Authority
AR
Argentina
Prior art keywords
medicines
manufacture
treatment
triptolid
autoimmune diseases
Prior art date
Application number
ARP980102327A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of AR012723A1 publication Critical patent/AR012723A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Derivados triptolidos de formulas (I),donde X es I, Br, Cl, F o -CN; R1 y R2 son cada uno independientemente H o -OR5; R3 es H, -C(=O) (CH2)nCO2H o unaminoácido adecuado; R4 es H o -OH; R5 es H, -C(=O)(CH2)nCO2H o un aminoácido adecuado, y n es el numero entero 2, 3, 4, 5 o 6, y sus estereoisomeros,enantiomeros y sales farmacéuticamente aceptables, con la condicion de que R1 y R2 sean H cuando R3 sea distinto de H. Dichos derivados se usan en lafabricacion de medicamentos para tratamientode un paciente que sufre una enfermedad autoinmune, consistente en administrar a dicho paciente unacantidad efectiva de los derivados triptolidos definidos más arriba.
ARP980102327A 1997-05-23 1998-05-20 Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos AR012723A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86248897A 1997-05-23 1997-05-23

Publications (1)

Publication Number Publication Date
AR012723A1 true AR012723A1 (es) 2000-11-08

Family

ID=25338616

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102327A AR012723A1 (es) 1997-05-23 1998-05-20 Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos

Country Status (21)

Country Link
EP (1) EP0983275B1 (es)
JP (1) JP2001525851A (es)
KR (1) KR20010012822A (es)
CN (1) CN1257507A (es)
AR (1) AR012723A1 (es)
AT (1) ATE222910T1 (es)
AU (1) AU741917B2 (es)
BR (1) BR9809678A (es)
CA (1) CA2287977A1 (es)
DE (1) DE69807466T2 (es)
DK (1) DK0983275T3 (es)
ES (1) ES2178207T3 (es)
HK (1) HK1026096A1 (es)
HU (1) HUP0003398A3 (es)
IL (1) IL133088A0 (es)
NO (1) NO995723L (es)
NZ (1) NZ500762A (es)
PT (1) PT983275E (es)
TW (1) TW434235B (es)
WO (1) WO1998052951A1 (es)
ZA (1) ZA984174B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329148B1 (en) 1999-02-16 2001-12-11 The Board Of Trustees Of The Leland Stanford University Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells
EP1390358A4 (en) * 2001-03-15 2004-06-16 Pharmagenesis Inc AMINO ACID DERIVATIVES OF TRIPTOLIDE COMPOUNDS AS IMMUNOMODULATORS AND ANTICROPHES
EP2468277A1 (en) * 2002-05-31 2012-06-27 Pharmagenesis, Inc. Triptolide derivatives for modulation of apoptosis and immunosuppression
CN100398544C (zh) * 2002-09-18 2008-07-02 成都达远药物有限公司 高免疫抑制活性的水溶性雷公藤内酯醇衍生物及其应用
EP1581208A1 (en) * 2002-12-17 2005-10-05 Pharmagenesis, Inc. Triptolide derivatives as immunomodulator and anticancer agents
CN1223595C (zh) 2002-12-27 2005-10-19 中国科学院上海药物研究所 雷公藤内酯醇衍生物及其应用
US6943259B2 (en) * 2003-02-25 2005-09-13 Pharmagenesis, Inc. Halogenated triptolide derivatives as immunomodulators and anticancer agents
WO2005062913A2 (en) 2003-12-24 2005-07-14 Pharmagenesis, Inc. Triplide 5,6-derivatives as immunomodulators and anticancer agents
US8048914B2 (en) 2004-02-09 2011-11-01 Pharmagenesis, Inc. Methods for isolation of triptolide compounds from Tripterygium wilfordii
AU2005218610B2 (en) 2004-03-02 2011-08-18 Pharmagenesis, Inc. Triptolide lactone ring derivatives as immunomodulators and anticancer agents
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US8617906B2 (en) 2004-10-13 2013-12-31 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
JP5653939B2 (ja) * 2009-02-05 2015-01-14 ファーマジェネシス， インコーポレイテッド 抗癌剤および免疫調節因子としてのトリプトリドｃ環誘導体
CA2977559C (en) * 2015-10-29 2022-04-12 Hangzhou Weben Pharmaceuticals Inc C14-hydroxyl esterified amino acid derivative of triptolide, and preparation method and use thereof
CN114716503B (zh) * 2022-03-23 2024-03-12 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 一种雷公藤氯内酯醇的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005108A (en) * 1973-04-03 1977-01-25 Research Corporation Novel anti-leukemic diterpenoid triepoxides
US5430054A (en) * 1989-12-22 1995-07-04 Jiangsu Family Planning Institute Preparation methods of diterpene lactone compounds and application of the same to antifertility
US5663335A (en) * 1996-03-01 1997-09-02 Pharmagenesis, Inc. Immunosuppressive compounds and methods

Also Published As

Publication number Publication date
ATE222910T1 (de) 2002-09-15
CA2287977A1 (en) 1998-11-26
WO1998052951A1 (en) 1998-11-26
NO995723L (no) 2000-01-21
ES2178207T3 (es) 2002-12-16
TW434235B (en) 2001-05-16
AU741917B2 (en) 2001-12-13
DE69807466T2 (de) 2003-04-24
NZ500762A (en) 2001-08-31
AU7260798A (en) 1998-12-11
DK0983275T3 (da) 2002-12-23
JP2001525851A (ja) 2001-12-11
ZA984174B (en) 1998-11-23
PT983275E (pt) 2003-01-31
KR20010012822A (ko) 2001-02-26
EP0983275A1 (en) 2000-03-08
CN1257507A (zh) 2000-06-21
EP0983275B1 (en) 2002-08-28
HUP0003398A2 (en) 2001-03-28
NO995723D0 (no) 1999-11-22
HK1026096A1 (en) 2000-12-01
BR9809678A (pt) 2000-07-11
DE69807466D1 (de) 2002-10-02
HUP0003398A3 (en) 2001-09-28
IL133088A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
AR012723A1 (es) Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos
AR050261A2 (es) Aminoacidos con afinidad por la proteina alfa-2-delta y composiciones farmaceuticas que los contienen y su uso para preparar un medicamento
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
RU99105213A (ru) Применение хелатирующего агента клиохинола для производства фармацевтической композиции для лечения болезни альцгеймера
SE9504661D0 (sv) New compounds
PA8432901A1 (es) Compuestos de piridilpirrol
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
AR012588A1 (es) UN INHIBIDOR DE SERINA PROTEASA, UNA COMPOSICIoN FARMACEUTICA QUE LO COMPRENDE Y UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICIoN FARMACEUTICA
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
ES2142030T3 (es) Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE68904586D1 (de) Histamin-derivat, verfahren zu dessen herstellung und therapeutischen anwendung.
DK0998287T3 (da) Anvendelse af levobupivacain
DK1039900T3 (da) Farmaceutisk præparat indeholdende sibutramin og orlistat
ATE123944T1 (de) Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
MX163574B (es) Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido
ES2041705T3 (es) Procedimiento para la preparacion de 1-(4-hidroxi-3,5-di-terc-butil-benzoil)-homopiperazina y sus derivados.
AR012737A1 (es) Derivados de triptolida utiles en el tratamiento de las enfermedades autoinmunes y usos en la fabricacion de medicamentos
AR007088A1 (es) 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas
DK0583271T3 (da) Arylmorpholin, fremstilling og anvendelse
SE9504662D0 (sv) New compounds
NO840526L (no) Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
IT1164387B (it) Derivati n-sostituiti dell'1-(4'-alchilsulfonilfenil)-2-ammino-1,3-propandiolo

Legal Events

Date Code Title Description
FB Suspension of granting procedure